184 related articles for article (PubMed ID: 27845245)
1. MR elastography of hepatocellular carcinoma: Correlation of tumor stiffness with histopathology features-Preliminary findings.
Thompson SM; Wang J; Chandan VS; Glaser KJ; Roberts LR; Ehman RL; Venkatesh SK
Magn Reson Imaging; 2017 Apr; 37():41-45. PubMed ID: 27845245
[TBL] [Abstract][Full Text] [Related]
2. 3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence.
Wang J; Shan Q; Liu Y; Yang H; Kuang S; He B; Zhang Y; Chen J; Zhang T; Glaser KJ; Zhu C; Chen J; Yin M; Venkatesh SK; Ehman RL
J Magn Reson Imaging; 2019 Mar; 49(3):719-730. PubMed ID: 30260529
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of 3D magnetic resonance elastography for assessing histologic grade of hepatocellular carcinoma: comparison of three methods for positioning region of interest.
Liu W; Rong D; Zhu J; Xiao Y; Zhang L; Deng Y; Chen J; Yin M; Venkatesh SK; Ehman RL; Wang J
Abdom Radiol (NY); 2021 Oct; 46(10):4601-4609. PubMed ID: 34085091
[TBL] [Abstract][Full Text] [Related]
4. Tumor Stiffness Measurements on MR Elastography for Single Nodular Hepatocellular Carcinomas Can Predict Tumor Recurrence After Hepatic Resection.
Park SJ; Yoon JH; Lee DH; Lim WH; Lee JM
J Magn Reson Imaging; 2021 Feb; 53(2):587-596. PubMed ID: 32914909
[TBL] [Abstract][Full Text] [Related]
5. Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy.
Gordic S; Ayache JB; Kennedy P; Besa C; Wagner M; Bane O; Ehman RL; Kim E; Taouli B
Abdom Radiol (NY); 2017 Jun; 42(6):1685-1694. PubMed ID: 28154910
[TBL] [Abstract][Full Text] [Related]
6. Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment.
Cho HJ; Kim B; Kim HJ; Huh J; Kim JK; Lee JH; Seo CW; Ahn HR; Eun JW; Kim SS; Cho SW; Cheong JY
Eur Radiol; 2020 Aug; 30(8):4182-4192. PubMed ID: 32189053
[TBL] [Abstract][Full Text] [Related]
7. The value of quantitative MR elastography-based stiffness for assessing the microvascular invasion grade in hepatocellular carcinoma.
Zhang L; Li M; Zhu J; Zhang Y; Xiao Y; Dong M; Zhang L; Wang J
Eur Radiol; 2023 Jun; 33(6):4103-4114. PubMed ID: 36435877
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC.
Qayyum A; Hwang KP; Stafford J; Verma A; Maru DM; Sandesh S; Sun J; Pestana RC; Avritscher R; Hassan MM; Amin H; Rashid A; Wistuba II; Ehman RL; Ma J; Kaseb AO
J Immunother Cancer; 2019 Nov; 7(1):329. PubMed ID: 31779702
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance elastography can predict development of hepatocellular carcinoma with longitudinally acquired two-point data.
Ichikawa S; Motosugi U; Enomoto N; Onishi H
Eur Radiol; 2019 Feb; 29(2):1013-1021. PubMed ID: 30043162
[TBL] [Abstract][Full Text] [Related]
10. Liver stiffness measured by magnetic resonance elastography as a risk factor for hepatocellular carcinoma: a preliminary case-control study.
Motosugi U; Ichikawa T; Koshiishi T; Sano K; Morisaka H; Ichikawa S; Enomoto N; Matsuda M; Fujii H; Araki T
Eur Radiol; 2013 Jan; 23(1):156-62. PubMed ID: 22814828
[TBL] [Abstract][Full Text] [Related]
11. Value of MR elastography for the preoperative estimation of liver regeneration capacity in patients with hepatocellular carcinoma.
Jang S; Lee JM; Lee DH; Joo I; Yoon JH; Chang W; Han JK
J Magn Reson Imaging; 2017 Jun; 45(6):1627-1636. PubMed ID: 27859840
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Hepatocellular Carcinoma by Liver Stiffness Measurements Using Magnetic Resonance Elastography After Eradicating Hepatitis C Virus.
Kumada T; Toyoda H; Yasuda S; Sone Y; Ogawa S; Takeshima K; Tada T; Ito T; Sumida Y; Tanaka J
Clin Transl Gastroenterol; 2021 Apr; 12(4):e00337. PubMed ID: 33888672
[TBL] [Abstract][Full Text] [Related]
13. Hepatic stiffness measurement by using MR elastography: prognostic values after hepatic resection for hepatocellular carcinoma.
Lee DH; Lee JM; Yi NJ; Lee KW; Suh KS; Lee JH; Lee KB; Han JK
Eur Radiol; 2017 Apr; 27(4):1713-1721. PubMed ID: 27456966
[TBL] [Abstract][Full Text] [Related]
14. Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma.
Kim B; Kim SS; Cho SW; Cheong JY; Huh J; Kim JK; Lee JH; Ahn HR; Cho HJ
Eur Radiol; 2021 Apr; 31(4):2507-2517. PubMed ID: 33033862
[TBL] [Abstract][Full Text] [Related]
15. Tumor stiffness measured by 3D magnetic resonance elastography can help predict the aggressiveness of endometrial carcinoma: preliminary findings.
Zhang L; Long X; Nijiati M; Zhang T; Li M; Deng Y; Kuang S; Xiao Y; Zhu J; He B; Chen J; Rossman P; Glaser KJ; Venkatesh SK; Ehman RL; Wang J
Cancer Imaging; 2021 Aug; 21(1):50. PubMed ID: 34454623
[TBL] [Abstract][Full Text] [Related]
16. Effects of vascularity and differentiation of hepatocellular carcinoma on tumor and liver stiffness: in vivo and in vitro studies.
Ling W; Lu Q; Lu C; Quan J; Ma L; Li J; He D; Liu J; Yang J; Wen T; Wu H; Zhu H; Luo Y
Ultrasound Med Biol; 2014 Apr; 40(4):739-46. PubMed ID: 24412176
[TBL] [Abstract][Full Text] [Related]
17. Use of magnetic resonance elastography for assessing liver functional reserve: A clinical study.
Li B; Min J; Liang WR; Zhang GQ; Wu JJ; Jin K; Huang W; Ying CY; Chao M
World J Gastroenterol; 2015 Jun; 21(24):7522-8. PubMed ID: 26139999
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Role of Liver Stiffness Measurements Using Magnetic Resonance Elastography in Patients with Compensated Chronic Liver Disease.
Lee DH; Lee JM; Chang W; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
Eur Radiol; 2018 Aug; 28(8):3513-3521. PubMed ID: 29488082
[TBL] [Abstract][Full Text] [Related]
19. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB
Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845
[TBL] [Abstract][Full Text] [Related]
20. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
